FDA Adverse Event Malfunction Summary report: N

IVENIX INC.

MDR report key: 20322805 · Received September 27, 2024

Report

Report Number
3014732157-2024-00698
Event Type
Malfunction
Date Received
September 27, 2024
Date of Event
September 4, 2024
Report Date
October 11, 2024
Manufacturer
FRESENIUS KABI USA LLC
Product Code
FPA
UDI-DI
00811505030030
PMA / PMN Number
K183311
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
WI, US
Reporter Occupation
OTHER
Health Professional
N

Narratives

Description of Event or Problem · 0

NO SAMPLE OR PICTURE WAS AVAILABLE FOR ANALYSIS. WITHOUT THE PROPER SAMPLE OR PICTURE EVALUATION IT IS NOT POSSIBLE TO DETERMINE THE PROBABLE ROOT CAUSE OF THE REPORTED FAILURE. THEREFORE, THE CUSTOMER COMPLAINT CANNOT BE CONFIRMED. THE POSSIBLE ROOT CAUSE MAY BE RELATED TO 1) AN OCCLUSION IN THE CASSETTE PORT WHERE THE IV TUBE IS PLACED DUE TO EXCESS ADHESIVE (LOCTITE) APPLIED TO THE CONNECTION AND 2) LOCTITE DISPENSER EQUIPMENT FAILURE OR AN INCORRECT SETUP OF THIS EQUIPMENT. THE BATCH RECORDS FOR BATCH FA23K20371 WERE REVIEWED. NO EXCEPTIONS WERE GENERATED THAT COULD CLASSIFY AS A POSSIBLE ROOT CAUSE OF THIS DEFECT. THE FINISHED GOOD LOT HAS PASSED ALL SAMPLING ACCEPTANCE CRITERIA FOR ALL TESTS PERFORMED INCLUDING IN-PROCESS TESTING AND PRODUCT TESTING. THE CURRENT PROCESS CONTROLS DETECTION INCLUDE 1) 100% LEAK AND OCCLUSION TEST IS PERFORMED THROUGH THE LEAK AND OCCLUSION TEST MACHINE IN ORDER TO CAPTURE UNITS WITH ANY BLOCKAGE OR LEAK FAILURE MODE, 2) FINAL PHYSICAL INSPECTION RELATED TO OCCLUSIONS ON THE ADMIN SET AND 3) 100% VISUAL INSPECTION USING BLACK LIGHT, THE ASSOCIATE ENSURES THAT THE UV CURING ON THIS CASSETTE ASSEMBLY IS CORRECT.

Description of Event or Problem · 0

THE FOLLOWING HAS BEEN REPORTED: CUSTOMER REPORTED: BLOOD ADMINISTRATION TUBING SALINE BAG WAS SPIKED AND THE NURSES COULDN'T PRIME THE TUBING - SALINE STOPPED BEFORE CASSETTE AND COULDN'T GET IT TO ADVANCE. GRABBED A NEW SET OF TUBING AND THEN IT WORKED JUST FINE. WAITING FOR CONFIRMATION OF NO PATIENT HARM. A PRELIMINARY REVIEW OF THE LOGS IDENTIFIED THE FOLLOWING ISSUE: POTENTIAL BLOCKAGE AT THE SECONDARY PORT. UNKNOWN IF AN ACTIVE INFUSION WAS STOPPED. REPORTING AS A CONSERVATIVE MEASURE. NO ADVERSE EFFECTS WERE REPORTED. ADDITIONAL INFORMATION IS NEEDED TO COMPLETE THE INVESTIGATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1611112 IVENIX INC. LVP BLOOD PRODUCTS ADMINISTRATION SET, DUAL-INLET, LOW-SORBING, YSITE, MESH FIL FPA FRESENIUS KABI USA LLC SET-0014-1 00811505030030

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown